*** FEATURED STUDY*** Perinatal Mesenchymal Stromal Cells: A Promising Avenue for Rheumatoid Arthritis Treatment
Current rheumatoid arthritis (RA) treatments focus on symptom management, but long-term disease remission remains challenging. Recent research examines the potential of perinatal mesenchymal stromal cells (MSCs) to modulate immune responses and reduce joint damage.
